Items where Author is "El-Sherbiny, Y"

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 6.

Journal article

EL-JAWHARI, J.J., KLEFTOURIS, G., EL-SHERBINY, Y., SALEEB, H., WEST, R.M., JONES, E. and GIANNOUDIS, P.V., 2019. Defective proliferation and osteogenic potential with altered immunoregulatory phenotype of native bone marrow-multipotential stromal cells in atrophic fracture non-union. Scientific Reports, 9 (1): 17340. ISSN 2045-2322

SELEEM, A.K., AZIZ EL REFAEEY, A., SHAALAN, D., EL-SHERBINY, Y. and BADAWY, A., 2014. Superoxide dismutase in polycystic ovary syndrome patients undergoing intracytoplasmic sperm injection. Journal of Assisted Reproduction and Genetics, 31 (4), pp. 499-504. ISSN 1058-0468

DAS, S., VITAL, E.M., HORTON, S., BRYER, D., EL-SHERBINY, Y., RAWSTRON, A.C., PONCHEL, F., EMERY, P. and BUCH, M.H., 2014. Abatacept or tocilizumab after rituximab in rheumatoid arthritis? An exploratory study suggests non-response to rituximab is associated with persistently high IL-6 and better clinical response to IL-6 blocking therapy. Annals of the Rheumatic Diseases, 73 (5), pp. 909-912. ISSN 0003-4967

PONCHEL, F., GOËB, V., PARMAR, R., EL-SHERBINY, Y., BOISSINOT, M., EL JAWHARI, J., BURSKA, A., VITAL, E.M., HARRISON, S., CONAGHAN, P.G., HENSOR, E. and EMERY, P., 2014. An immunological biomarker to predict MTX response in early RA. Annals of the Rheumatic Diseases, 73 (11), pp. 2047-2053. ISSN 0003-4967

Chapter in book

KOUROUPIS, D., WANG, X.N., EL-SHERBINY, Y., MCGONAGLE, D. and JONES, E., 2017. The safety of non-expanded multipotential stromal cell therapies. In: P. VAN PHAM and A. ROSEMANN, eds., Safety, ethics and regulations. Stem cells in clinical applications (SCCA) . Cham: Springer, pp. 91-118. ISBN 9783319591643

Patent/Published patent application

MCGOANGLE, D., JONES, E., EL-SHERBINY, Y. and MOSELEY, T., 2017. Immunomodulation with implantation of cellular allograft bone into a non-bony site. 1202617.

This list was generated on Tue Dec 10 03:46:35 2019 UTC.